EPISODE · Sep 13, 2010 · 22 MIN
Banking On Vaccine For EV71
from The Breakfast Grille · host BFM Media
Peter Wulff, co-founder of Sentinext Theraputics, tells why the biotechnology company is banking on developing the vaccine for EV71, a virus that has been spreading in Asia. While incidences of deaths may be relatively low, survivors may suffer neural damage. The company needs to raise about $1 billion to bring the drug to the market. Currently it's funded by funds from the Malaysian government. See omnystudio.com/listener for privacy information.
NOW PLAYING
Banking On Vaccine For EV71
No transcript for this episode yet
Similar Episodes
No similar episodes found.